Stephen C. L. Koh

657 total citations
27 papers, 515 citations indexed

About

Stephen C. L. Koh is a scholar working on Hematology, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stephen C. L. Koh has authored 27 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Obstetrics and Gynecology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stephen C. L. Koh's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Pregnancy and preeclampsia studies (5 papers) and Blood properties and coagulation (5 papers). Stephen C. L. Koh is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Pregnancy and preeclampsia studies (5 papers) and Blood properties and coagulation (5 papers). Stephen C. L. Koh collaborates with scholars based in Singapore, Indonesia and Sweden. Stephen C. L. Koh's co-authors include S.S. Ratnam, Mahesh Choolani, S. S. Ratnam, Arijit Biswas, Kuldip Singh, Kothandaraman Narasimhan, O. A. C. Viegas, A. Ilancheran, Rajendra Prasad and Huoming Zhang and has published in prestigious journals such as Anesthesia & Analgesia, Thrombosis and Haemostasis and Human Pathology.

In The Last Decade

Stephen C. L. Koh

27 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen C. L. Koh Singapore 16 154 134 90 86 84 27 515
Elena Del Ferro Italy 14 153 1.0× 146 1.1× 44 0.5× 92 1.1× 199 2.4× 22 794
Aurélie Rousseau France 12 161 1.0× 59 0.4× 57 0.6× 26 0.3× 8 0.1× 34 393
Sriya Gunawardena United States 13 286 1.9× 18 0.1× 60 0.7× 30 0.3× 14 0.2× 34 486
Miğraci Tosun Türkiye 14 18 0.1× 392 2.9× 195 2.2× 150 1.7× 191 2.3× 44 690
Gail T. McDonald Canada 8 28 0.2× 99 0.7× 47 0.5× 32 0.4× 21 0.3× 17 317
D. Parker United Kingdom 11 32 0.2× 28 0.2× 120 1.3× 182 2.1× 115 1.4× 20 546
Paulina B. Szklanna Ireland 13 137 0.9× 78 0.6× 36 0.4× 12 0.1× 6 0.1× 26 435
Hyun Soo Ahn South Korea 15 88 0.6× 15 0.1× 28 0.3× 55 0.6× 42 0.5× 55 599
Павел Зак Czechia 15 164 1.1× 27 0.2× 44 0.5× 68 0.8× 3 0.0× 89 562
S Kaufman Israel 11 185 1.2× 8 0.1× 23 0.3× 44 0.5× 35 0.4× 30 688

Countries citing papers authored by Stephen C. L. Koh

Since Specialization
Citations

This map shows the geographic impact of Stephen C. L. Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. L. Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. L. Koh more than expected).

Fields of papers citing papers by Stephen C. L. Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. L. Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. L. Koh. The network helps show where Stephen C. L. Koh may publish in the future.

Co-authorship network of co-authors of Stephen C. L. Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. L. Koh. A scholar is included among the top collaborators of Stephen C. L. Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. L. Koh. Stephen C. L. Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koh, Stephen C. L., et al.. (2019). The Vascular Endothelium in Patients with Dengue Haemorrhagic Fever. Open Access Macedonian Journal of Medical Sciences. 7(14). 2221–2225. 7 indexed citations
2.
Koh, Stephen C. L., et al.. (2016). Soluble vascular cell adhesion molecule-1 and magnesium sulfate with nifedipine treatment in Indonesian women with severe pre-eclampsia. Interventional Medicine and Applied Science. 8(3). 97–102. 7 indexed citations
3.
Chong, Mark Seow Khoon, Swee‐Hin Teoh, Erin Yiling Teo, et al.. (2010). Beyond Cell Capture: Antibody Conjugation Improves Hemocompatibility for Vascular Tissue Engineering Applications. Tissue Engineering Part A. 16(8). 2485–2495. 26 indexed citations
4.
Koh, Stephen C. L. & Kuldip Singh. (2010). Levonorgestrel‐intrauterine system effects on hemostasis and menstrual blood loss in women seeking contraception. Journal of obstetrics and gynaecology research. 36(4). 838–844. 5 indexed citations
5.
Koh, Stephen C. L., Khalil Razvi, Y. H. Chan, et al.. (2010). The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer. Archives of Gynecology and Obstetrics. 284(1). 183–190. 26 indexed citations
6.
Loganath, A., Changfa Guo, Kothandaraman Narasimhan, et al.. (2007). Circulating Haptoglobin Is an Independent Prognostic Factor in the Sera of Patients with Epithelial Ovarian Cancer. Neoplasia. 9(1). 1–7. 71 indexed citations
7.
Koh, Stephen C. L., et al.. (2006). The Association between Fibrinogen, von Willebrand Factor, Antithrombin III, and D-dimer Levels and Survival Outcome by 36 Months from Ovarian Cancer. Clinical and Applied Thrombosis/Hemostasis. 12(1). 3–8. 34 indexed citations
8.
Liu, Eugene H. C., et al.. (2000). An Assessment of the Effects on Coagulation of Midtrimester and Final-Trimester Amniotic Fluid on Whole Blood by Thrombelastograph® Analysis. Anesthesia & Analgesia. 90(2). 333–336. 16 indexed citations
9.
Koh, Stephen C. L., O. A. C. Viegas, & S. S. Ratnam. (1999). A Prospective Study on the Effects of Reformulated 2‐rod Norplant Implant on Haemostasis after Five Years of Use. Journal of obstetrics and gynaecology research. 25(3). 177–183. 1 indexed citations
10.
11.
Koh, Stephen C. L., et al.. (1999). Effects on Hemostasis After Two-Year Use of Low Dose Combined Oral Contraceptives with Gestodene or Levonorgestrel. Clinical and Applied Thrombosis/Hemostasis. 5(1). 60–70. 30 indexed citations
12.
Koh, Stephen C. L., et al.. (1998). Preeclampsia: Haemostatic Status and the Short‐Term Effects of Methyldopa and Isradipine Therapy. Journal of obstetrics and gynaecology research. 24(3). 231–238. 19 indexed citations
13.
14.
Koh, Stephen C. L., C. Anandakumar, Sven Montán, & S. S. Ratnam. (1993). Plasminogen Activators, Plasminogen Activator Inhibitors and Markers of Intravascular Coagulation in Pre-Eclampsia. Gynecologic and Obstetric Investigation. 35(4). 214–221. 24 indexed citations
15.
Koh, Stephen C. L., et al.. (1991). Plasminogen Activators t-PA, u-PA and Its Inhibitor (PAI) in Normal Males and Females. Thrombosis and Haemostasis. 66(5). 581–585. 23 indexed citations
16.
Singh, Kuldip, et al.. (1989). Two-year follow-up of changes in clinical chemistry in Singaporean Norplant® acceptors: Haemostatic changes. Contraception. 39(2). 137–146. 4 indexed citations
17.
Singh, Kuldip, et al.. (1989). Two-year follow-up of changes in clinical chemistry in Singaporean Norplant®-2 rod acceptors: Haemostatic changes. Contraception. 39(2). 155–164. 20 indexed citations
18.
Koh, Stephen C. L., et al.. (1989). Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function. Contraception. 39(4). 369–383. 34 indexed citations
19.
Singh, Kuldip, et al.. (1988). The effects of NORPLANT® on clinical chemistry in singaporean acceptors after 1 year of use: I. Haehostatic changes. Contraception. 38(3). 313–323. 8 indexed citations
20.
Singh, Kuldip, et al.. (1988). The effects of norplant®-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: Haehostatic changes. Contraception. 38(4). 441–451. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Del Ferro Breakdown of academic impact, for papers by Aurélie Rousseau Breakdown of academic impact, for papers by Sriya Gunawardena Breakdown of academic impact, for papers by Miğraci Tosun Breakdown of academic impact, for papers by Gail T. McDonald Breakdown of academic impact, for papers by D. Parker Breakdown of academic impact, for papers by Paulina B. Szklanna Breakdown of academic impact, for papers by Hyun Soo Ahn Breakdown of academic impact, for papers by Павел Зак Breakdown of academic impact, for papers by S Kaufman
Rankless by CCL
2026